Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice

AG Zermansky, DR Petty, DK Raynor, N Freemantle… - Bmj, 2001 - bmj.com
Objective: To determine whether a pharmacist can effectively review repeat prescriptions
through consultations with elderly patients in general practice. Design: Randomised controlled …

Medication reviews

…, C Bond, DK Raynor - British journal of clinical …, 2012 - Wiley Online Library
Recent years have seen a formalization of medication review by pharmacists in all settings
of care. This article describes the different types of medication review provided in primary …

The role and value of written information for patients about individual medicines: a systematic review

J Grime, A Blenkinsopp, DK Raynor… - Health …, 2007 - Wiley Online Library
Objective To review research on the role and value of written medicines information for
patients from the perspective of patients and health professionals. Context Providing written …

Clinical medication review by a pharmacist of elderly people living in care homes—randomised controlled trial

…, DP Alldred, DR Petty, DK Raynor… - Age and …, 2006 - academic.oup.com
Objective: to measure the impact of pharmacist-conducted clinical medication review with
elderly care home residents. Design: randomised controlled trial of clinical medication review …

Care homes' use of medicines study: prevalence, causes and potential harm of medication errors in care homes for older people

ND Barber, DP Alldred, DK Raynor… - BMJ Quality & …, 2009 - qualitysafety.bmj.com
Introduction: Care home residents are at particular risk from medication errors, and our
objective was to determine the prevalence and potential harm of prescribing, monitoring, …

Comparison of two methods of presenting risk information to patients about the side effects of medicines

P Knapp, DK Raynor, DC Berry - BMJ Quality & Safety, 2004 - qualitysafety.bmj.com
DK Raynor1, … Berry DC, Knapp P, Raynor DK. Provision of information about drug side
effects to … Berry DC, Raynor DK, Knapp P. Communicating risk of medication side effects: an …

Provision of information about drug side-effects to patients

DC Berry, P Knapp, DK Raynor - The Lancet, 2002 - thelancet.com
DK Raynor had the original idea for the pilot study, and DC Berry for the three studies. All
authors contributed to study design, interpretation of findings, and writing of the report. DC …

[HTML][HTML] Buyer beware? Does the information provided with herbal products available over the counter enable safe use?

DK Raynor, R Dickinson, P Knapp, AF Long… - BMC medicine, 2011 - Springer
Background Herbal products obtained over the counter are commonly used in Europe, North
America and Australia. Although there is concern about a lack of information provided to …

Patient information leaflets for medicines: using consumer testing to determine the most effective design

D Dickinson, DK Raynor, M Duman - Patient education and counseling, 2001 - Elsevier
Comprehensive medicine information leaflets for patients are now mandatory across the
European Union. In 1997, the European Commission (EC) proposed a prescriptive ‘model’ for …

We are the experts: people with asthma talk about their medicine information needs

DK Raynor, I Savage, P Knapp, J Henley - Patient education and …, 2004 - Elsevier
People with chronic illness are being encouraged to become more involved in their care.
For this, they need to be well informed about their medicines, and more written medicines …